Related Experiment Video
Updated: Sep 15, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
USP39: a key regulator in malignant tumor progression.
Junyan Li1, Jinghua Zhong2,3, Jianming Ye2,3
1The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Ubiquitin-specific protease 39 (USP39) regulates pre-mRNA splicing and promotes cancer progression. This review explores USP39
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ubiquitin-specific protease 39 (USP39) is a USP family member.
- USP39 uniquely regulates pre-mRNA splicing beyond deubiquitination.
- USP39 is implicated as a pro-tumor factor in malignant tumors.
Purpose of the Study:
- To comprehensively review USP39's structure and function in cancer.
- To elucidate USP39's role in malignant tumor progression and therapy resistance.
- To explore novel strategies for USP39-targeted inhibitor development.
Main Methods:
- Literature review of USP39's structure and function.
- Analysis of USP39's involvement in various cancer types.
- Exploration of USP39's role in drug resistance mechanisms.
Main Results:
- USP39 regulates pre-mRNA splicing, influencing cancer growth, proliferation, and metastasis.
- USP39 contributes to resistance against antitumor therapies.
- USP39's structure and function offer a basis for targeted inhibitor design.
Conclusions:
- USP39 is a critical regulator of malignant tumor progression.
- Targeting USP39 presents a promising therapeutic strategy for cancer treatment.
- Novel USP39 inhibitors can be developed based on its unique characteristics.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...